§ Funding Round
Series B funding round for Capstan Therapeutics raising $180M in March 2024
Series B funding round for Capstan Therapeutics raising $180M in March 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | ed mathers | |
| Organization | — | |
Pureos Bioventures | — | — |
| Organization | — | |
| Angel | vincent brichard | |
| Angel | Olivier Pomel | |
| Angel | xavier niel | |
| Organization | — | |
Bristol Myers Squibb | — | — |
Eli Lilly and Company | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
nandita shangariLEAD | Angel | nandita shangari |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$280M
Top Valuation
-
Capstan Therapeutics raised $180M in a Series B round.
The round was announced on 03/01/24.
The round was led by nandita shangari.
